You must be registered for the ASBMR annual meeting to attend this live in person presentation.
X-linked hypophosphatemia (XLH) is the most common heritable form of rickets, affecting approximately 1 in 20,000 individuals. Characterized by stunted growth with disproportionate short stature, lower limb bowing, reduced motor function, osteoarticular pain, hypotonia, and dental and periodontal complications, XLH is a progressive, lifelong bone disorder. Despite increasing recognition of the disease, diagnosis is often delayed, and many patients do not receive timely or appropriate treatment, resulting in preventable long-term morbidity.
With the release of new global clinical practice guidelines for X-linked hypophosphatemia (XLH), opportunities have emerged to improve early recognition and optimize lifelong management. Using pediatric and adult case studies, this CME-accredited activity reviews consensus recommendations, strategies for early diagnosis, risk assessment, long-term monitoring, and approaches to individualized treatment, including who to treat and when. Current and emerging therapies will also be discussed.
Join us as we discuss actual patient cases using the new guidelines demonstrating improvement in patient diagnosis and outcomes
Schedule |
|
| * Times are EST | |
| 12:45 PM | Registration and Boxed Lunches |
| 12:55 PM | Welcome, Disclosure, Supporter Acknowledgement |
| 01:00 PM |
Overview of Newly Published International XLH Treatment Guidelines
Key recommendations, evidence base, and implications for endocrinology practice |
| 01:50 PM | Audience Q&A |
| 02:00 PM | Adjourn |
| 02:00 PM | Online evaluation |
Jill H. Simmons, MD
Interim Director, Division of Pediatric Endocrinology
Professor of Pediatrics, Pediatric Endocrinology
Director, Program for Pediatric Metabolic Bone Disorders
Vice Chair for Faculty Development, Department of Pediatrics
Member, VUMC Academy for Excellence in Education
Vanderbilt University Medical Center
Nashville, TN
Thomas J. Weber, MD
Medical Director, Duke Clinical Bone Laboratory
Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University Medical Center
Durham, NC
EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
EXCEL Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Canadian CME: Through an agreement between the ACCME and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 1 of the Royal College’s MOC Program.
The UEMS-EACCME®: The American Medical Association has an agreement of mutual recognition of CME credit with the UEMS (European Union of Medical Specialists). Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.
Physician Assistants: AAPA and the NCCPA accept AMA Category 1 Credit™ from organizations accredited by the ACCME.
Nurse Practitioners: AANP and the ANCC accept AMA Category 1 Credit™ from organizations accredited by the ACCME.